Keywords: Pronova, Takeda, Lotriga, Astellas, Sanwa Kagaku, Argamate, Japan launch, Hyperlipidemia, Hyperkalemia

Japan launches for Lotriga and Argamate

Article | 11 January 2013

Print This

Norway’s Pronova BioPharma (OSE: PRON.OL), recently the subject of a $845 million takeover bid from Germany’s ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in